نتایج جستجو برای: درمان haart

تعداد نتایج: 47583  

Journal: :Archives of pediatrics & adolescent medicine 2006
Nathalie Ylitalo Susan Brogly Michael D Hughes Sharon Nachman Wayne Dankner Russell Van Dyke George R Seage

OBJECTIVE To examine the relationship between the use of highly active antiretroviral treatment (HAART) and the occurrence of opportunistic illnesses (OIs) among children perinatally infected with human immunodeficiency virus. DESIGN Prospective cohort study. SETTING Pediatric AIDS Clinical Trials Group 219C cohort. PARTICIPANTS From September 15, 2000, to August 31, 2003, 1927 children p...

Journal: :The Indian journal of medical research 2010
Surendra K Sharma Sahajal Dhooria Parag Barwad Tamilarasu Kadhiravan Sanjay Ranjan Sunita Miglani Deepak Gupta

BACKGROUND & OBJECTIVES A considerable proportion of patients with HIV associated tuberculosis (TB) started on highly active antiretroviral therapy (HAART) develop immune reconstitution inflammatory syndrome (IRIS), which is difficult to diagnose in a resource-limited setting. In view of the recently proposed consensus case-definitions for TB-IRIS for use in resource-limited settings we underto...

2017
Mehdi Gholamzadeh Baeis Ghasem Amiri Mojtaba Miladinia

OBJECTIVE This study examines the effect of the addition of IMOD, a novel multi-herbal drug to the highly active anti-retroviral therapy (HAART) regimen, on the immunological status of HIV-positive patients. MATERIALS AND METHODS A randomized two-parallel-group (HAART group versus HAART+IMOD group), pretest-posttest design was used.Sixty patients with indications for treatment with the HAART ...

Journal: :SADJ : journal of the South African Dental Association = tydskrif van die Suid-Afrikaanse Tandheelkundige Vereniging 2013
S R Mthethwa J Wanjau N Chabikuli

INTRODUCTION The overall prevalence of HIV associated oral lesions among adults has decreased since the advent of highly active anti-retroviral therapy (HAART). AIMS AND OBJECTIVES This study describes the prevalence and types of oral mucosal lesions in adults, who accepted a dedicated oral and dental programme for HIV-infected patients. The incidence of oral lesions and the CD4 cell counts o...

2017
Hugo Boechat Andrade Cassia Righy Shinotsuka Ivan Rocha Ferreira da Silva Camila Sunaitis Donini Ho Yeh Li Frederico Bruzzi de Carvalho Pedro Emmanuel Alvarenga Americano do Brasil Fernando Augusto Bozza Andre Miguel Japiassu

INTRODUCTION It is unclear whether the treatment of an HIV infection with highly active antiretroviral therapy (HAART) affects intensive care unit (ICU) outcomes. In this paper, we report the results of a systematic review and meta-analysis performed to summarize the effects of HAART on the prognosis of critically ill HIV positive patients. MATERIALS AND METHODS A bibliographic search was per...

Journal: :PLoS Pathogens 2007
Ahmad R Sedaghat Janet D Siliciano Timothy P Brennan Claus O Wilke Robert F Siliciano

Whereas cells productively infected with human immunodeficiency virus type 1 (HIV-1) decay rapidly in the setting of highly active antiretroviral therapy (HAART), latently infected resting CD4(+) T cells decay very slowly, persisting for the lifetime of the patient and thus forming a stable reservoir for HIV-1. It has been suggested that the stability of the latent reservoir is due to low-level...

Journal: :The Journal of clinical investigation 1999
G M Ortiz D F Nixon A Trkola J Binley X Jin S Bonhoeffer P J Kuebler S M Donahoe M A Demoitie W M Kakimoto T Ketas B Clas J J Heymann L Zhang Y Cao A Hurley J P Moore D D Ho M Markowitz

Therapeutic intervention with highly active antiretroviral therapy (HAART) can lead to suppression of HIV-1 plasma viremia to undetectable levels for 3 or more years. However, adherence to complex drug regimens can prove problematic, and subjects may temporarily discontinue HAART for variable periods. We studied 6 HIV-1-infected individuals who stopped therapy. Off HAART, levels of viremia were...

2010
Kim C Mansky

Highly active antiretroviral therapy (HAART) has had a profound impact on improving the long-term prognosis for individuals infected with human immunodeficiency virus (HIV). HAART has been available for close to two decades, and now a significant number of patients with access to HAART are over the age of 50 years. Many clinical studies have indicated that HIV infection, as well as components o...

Journal: :Salud publica de Mexico 2008
Sergio Bautista-Arredondo Tania Dmytraczenko Gilbert Kombe Stefano M Bertozzi

OBJECTIVE To determine the net effect of introducing highly active antiretroviral treatment (HAART) in Mexico on total annual per-patient costs for HIV/AIDS care, taking into account potential savings from treatment of opportunistic infections and hospitalizations. MATERIAL AND METHODS A multi-center, retrospective patient chart review and collection of unit cost data were performed to descri...

2016
Brenda Crabtree-Ramírez Yanink Caro-Vega Bryan E. Shepherd Beatriz Grinsztejn Marcelo Wolff Claudia P. Cortes Denis Padgett Gabriela Carriquiry Valeria Fink Karu Jayathilake Anna K. Person Catherine McGowan Juan Sierra-Madero

BACKGROUND Since 2009, earlier initiation of highly active antiretroviral therapy (HAART) after an opportunistic infection (OI) has been recommended based on lower risks of death and AIDS-related progression found in clinical trials. Delay in HAART initiation after OIs may be an important barrier for successful outcomes in patients with advanced disease. Timing of HAART initiation after an OI i...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید